<DOC>
	<DOCNO>NCT01269398</DOCNO>
	<brief_summary>Utilization trans-pedicular trans-discal implant stabilization single lumbar motion segment , conjunction posterior facet fusion . The trajectory plan achieve mean SpineAssist® system - computerize , image-based guidance system assist surgeon precisely guide spinal surgical tool implant line CT-based pre-operative plan . GO-LIF SpineAssist CE mark product . Thy study 's objective collect data regard ability achieve solide fusion , comibing GO-LIF procedure spinal fixation stabilization percutaneous posterior facet fusion .</brief_summary>
	<brief_title>GO-LIF With Percutaneous Facet Fusion</brief_title>
	<detailed_description />
	<criteria>1 . Skeletallymature patient require singlelevel instrument fusion L1 S1 2 . Men woman , 1880 year age . 3 . Unequivocal medical indication fixation surgery single motion segment lumbar spine . 4 . Correct coronal profile lumbar spine . An asymmetric collapse disk space coronal plane vertebral body envision instrumentation exclusion criterion . 5 . Patient may , require , secondary diagnosis one following : Degenerative spondylolisthesis ( Grades 1 2 ) sagittal plane preserve normal sagittal alignment Spinal stenosis ( Not exclude patient need decompression ) 6 . ODI cutoff inclusion , low equal 40 ODI 7 . VAS cutoff inclusion , low equal 9 8 . Patient willing able comply study requirement , include followup schedule postoperative management program 9 . Patient must understand sign inform consent 1 . Lumbar hyperlordosis &gt; 70° end plate lumbar vertebral body 1 end plate sacral vertebral body 1 . 2 . Deformities vertebral body envision instrumentation sacrum . 3 . Spondylolisthesis &gt; grade 2 acc . Meyerding . 4 . Scoliosis deformities coronal plane . 5 . Fractures vertebrae envision instrumentation . 6 . Osteoporosis osteopenia ( see examination criterion ) . 7 . Therapy systemic corticosteroid immunosuppressant . 8 . Bone metabolism disease , osteomalacia Paget 's disease . 9 . Post inflammatory instability vertebral spine . 10 . State radiation therapy relevant vertebral spine region . 11 . Current Marcoumar heparin therapy 6 month time operation . 12 . Malignant disease without bone metastasis . 13 . Immunologicinflammatory disease ( e.g. , rheumatoid arthritis ) . 14 . Diabetes mellitus . 15 . Infectious disease . 16 . More one motion segment require treatment . 17 . Prior percutaneous vertebral augmentation procedure ( e.g. , vertebroplasty , kyphoplasty ) index adjacent level . 18 . Prior fusion attempt involve level . 19 . Clinically radiographically compromise vertebral body superior vertebra affect level compromise pedicle inferior vertebra affect level due current past trauma Onyx Spinal System implant 20 . Active malignancy : A patient history invasive malignancy ( except nonmelanoma skin cancer ) , unless he/she treat curative intent clinical sign symptom malignancy least 5 year . 21 . Coagulopathy inability reverse anticoagulant therapy ( approximately 24 hour postprocedure ) . 22 . Metabolic bone disease Paget 's disease , osteopenia osteomalacia . 23 . Severe diabetes mellitus require daily insulin management . 24 . Haemorrhagic diasthesis . 25 . Coagulation disorder , severe cardiopulmonary disease . 26 . Active systemic infection ( include AIDS , HIV Hepatitis ) active infection surgical site . 27 . Rheumatoid arthritis autoimmune disease . 28 . Morbid obesity , define Body Mass Index 40 high 100 pound weight . 29 . Conditions medication may interfere bony/soft tissue healing ( e.g. , long term steroid use ) . 30 . Any medical condition would preclude patient surgery , impede benefit spinal implant surgery impede patient complete post operative rehabilitation plan . 31 . Pregnancy , current plan duration study . 32 . Subject history substance abuse ( e.g. , recreational drug , narcotic , alcohol ) within last 12 month . 33 . Known allergy titanium titanium alloy . 34 . Bone growth stimulator use anywhere body within last 30 day . 35 . In active spinal litigation . 36 . Degenerative spondylolisthesis ( Grades 3 ) 37 . Is currently involve study another investigational product similar purpose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>